{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:29:02Z","timestamp":1792290542844,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cyto.2024.156671","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T09:44:59Z","timestamp":1719567899000},"page":"156671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Ebselen improves lipid metabolism by activating PI3K\/Akt and inhibiting TLR4\/JNK signaling pathway to alleviate nonalcoholic fatty liver"],"prefix":"10.1016","volume":"181","author":[{"given":"Meimin","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianran","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156671_b0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156671_b0010","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.cyto.2024.156671_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cyto.2024.156671_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169196","article-title":"mTOR: A potential new target in nonalcoholic fatty liver disease","volume":"23","author":"Feng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0025","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4155\/fmc-2019-0218","article-title":"Mechanisms of ebselen as a therapeutic and its pharmacology applications","volume":"12","author":"Wang","year":"2020","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.cyto.2024.156671_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021610","article-title":"Antibacterial activity of Ebselen","volume":"24","author":"Ma\u015blanka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0035","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1016\/j.bbagen.2016.09.029","article-title":"Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells","volume":"1861","author":"Thangamani","year":"2017","journal-title":"Biochim. Biophys. Acta. Gen. Subj."},{"key":"10.1016\/j.cyto.2024.156671_b0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/molpharm.120.000184","article-title":"Cysteine modification by Ebselen reduces the stability and cellular levels of 14-3-3 proteins","volume":"100","author":"Wal\u00f8en","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cyto.2024.156671_b0045","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.7150\/ijbs.66314","article-title":"Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic mice","volume":"18","author":"Polianskyte-Prause","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0050","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates Non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168969","article-title":"Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPAR\u03b1","volume":"22","author":"Tahri-Joutey","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0060","first-page":"29","article-title":"SIRT6 Promotes hepatic beta-oxidation via activation of PPAR\u03b1","author":"Naiman","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.cyto.2024.156671_b0065","first-page":"19","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation","author":"Farzanegi","year":"2019","journal-title":"Eur. J. Sport. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0070","article-title":"Pharmacological effects and molecular protective mechanisms of astragalus polysaccharides on nonalcoholic fatty liver disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cyto.2024.156671_b0075","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food. Funct."},{"key":"10.1016\/j.cyto.2024.156671_b0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecoenv.2019.02.041","article-title":"Antioxidant, antiapoptotic, antigenotoxic, and hepatic ameliorative effects of L-carnitine and selenium on cadmium-induced hepatotoxicity and alterations in liver cell structure in male mice","volume":"173","author":"Abu-El-Zahab","year":"2019","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.cyto.2024.156671_b0085","doi-asserted-by":"crossref","first-page":"21828","DOI":"10.1007\/s11356-019-05397-3","article-title":"Effect of selenium nanoparticles against abnormal fatty acid metabolism induced by hexavalent chromium in chicken's liver","volume":"26","author":"Luo","year":"2019","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.cyto.2024.156671_b0090","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/0006-2952(84)90083-2","article-title":"A novel biologically active seleno-organic compound\u2013I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen)","volume":"33","author":"M\u00fcller","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cyto.2024.156671_b0095","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1007\/s11356-020-10955-1","article-title":"Protective efficacy of thymoquinone or ebselen separately against arsenic-induced hepatotoxicity in rat","volume":"28","author":"Al Aboud","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.cyto.2024.156671_b0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12011-018-1395-x","article-title":"Hematobiochemical disturbances and oxidative stress after subacute manganese chloride exposure and potential protective effects of Ebselen in rats","volume":"187","author":"Ismail","year":"2019","journal-title":"Biol. Trace. Elem. Res."},{"key":"10.1016\/j.cyto.2024.156671_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910545","article-title":"The role of PPAR alpha in the modulation of innate immunity","volume":"22","author":"Grabacka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cyto.2024.156671_b0115","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1073\/pnas.0538015100","article-title":"Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase","volume":"100","author":"Ziouzenkova","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2024.156671_b0120","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cyto.2024.156671_b0125","doi-asserted-by":"crossref","first-page":"e0199728","DOI":"10.1371\/journal.pone.0199728","article-title":"High-fat diet suppresses the positive effect of creatine supplementation on skeletal muscle function by reducing protein expression of IGF-PI3K-AKT-mTOR pathway","volume":"13","author":"Ferretti","year":"2018","journal-title":"PLoS. One."},{"key":"10.1016\/j.cyto.2024.156671_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114291","article-title":"Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective","volume":"235","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cyto.2024.156671_b0135","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1002\/jcp.26449","article-title":"WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4\/JNK signaling","volume":"233","author":"Jung","year":"2018","journal-title":"J. Cell. Physiol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:17:03Z","timestamp":1786792623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":27,"alternative-id":["S1043466624001741"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156671","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebselen improves lipid metabolism by activating PI3K\/Akt and inhibiting TLR4\/JNK signaling pathway to alleviate nonalcoholic fatty liver","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156671"}}